Globe Newswire News Releases

Mar 25, 2019 07:10 ET
Report: Exploring Fundamental Drivers Behind ON Semiconductor, Pilgrim's Pride, Merck & Co., Healthcare Services Group, Genomic Health, and Spectrum Pharmaceuticals — New Horizons, Emerging Trends, an
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ON Semiconductor Corporation (NASDAQ:ON), Pilgrim's Pride Corporation...
Mar 25, 2019 07:02 ET
Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806
Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that the U.S. Food and Drug...
Mar 25, 2019 07:00 ET
“If I Had Only Known” makes a difficult time easier for families and loved ones
Strategic Vision Publishing’s new offering, “If I Had Only Known” provides step-by-step instructions and worksheets to help families prepare for – and avoid – the most common missteps and challenges related to the death of a loved one. Authors...
Mar 25, 2019 07:00 ET
Allergy Season 2019 Expert Predictions: Early start for the Prairie provinces, late start for BC, and ‘normal’ start for the rest of Canada
Experts at Aerobiology Research Laboratories who specialize in pollen and spore identification and research in Canada, predict Alberta, Saskatchewan and Manitoba will see a much earlier start to the tree pollen season resulting in an early arrival...
Mar 25, 2019 07:00 ET
Amarillo Announces Resource Update With Total Measured and Indicated Resource of 29 Million Tonnes at 1.2 Grams per Tonne Gold for 1,200,000 Gold Ounces
Amarillo Gold Corporation (“Amarillo” or the “Company”) (TSX.V: AGC) (OTCQB: AGCBF) is pleased to announce an updated resource model for the Posse deposit at the Mara Rosa gold project in Goias State, Brazil.  This new resource model will be used...
Mar 25, 2019 07:00 ET
Arvinas Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of PROTAC™ Protein Degrader, ARV-110
Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company creating a new class of therapies that degrade disease-causing proteins, today announced the initiation of patient dosing in its Phase 1 clinical trial of ARV-110, the company’s oral...
Mar 25, 2019 07:00 ET
Brazil Minerals, Inc. Advances Its Nickel, Cobalt and Copper Project
via OTC PR WIRE -- Brazil Minerals, Inc. (OTC: BMIX) (the "Company" or "Brazil Minerals") announced today that it had been granted by the local mining authority the Exploration Permit for its nickel, cobalt and copper project that encompasses two...
Mar 25, 2019 07:00 ET
Canopy Rivers Portfolio Company Licensed by Health Canada, Triggering Long-Term Cash Flow Stream
Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) congratulates Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth”) and its portfolio company, Spot Therapeutics Inc. (“Spot”), on receiving a cultivation license from...
Mar 25, 2019 07:00 ET
Fraser Institute Media Advisory: What causes poverty, and how can Canadians avoid it? New study coming Tuesday, March 26
On Tuesday, March 26, the Fraser Institute will release a new study on poverty in Canada. Using data from Statistics Canada, Causes of Poverty spotlights the poverty rates for different types of households in Canada, and highlights key life...
Mar 25, 2019 07:00 ET
Hamilton Lane Incorporated to Host Inaugural Investor Conference on April 2, 2019
Hamilton Lane Incorporated (NASDAQ: HLNE) announced plans to host its first annual Investor Conference in New York City on Tuesday, April 2, 2019. A broad cross-section of Hamilton Lane’s management team will present on the company’s strategy,...
Mar 25, 2019 07:00 ET
iClick Interactive Asia Group Limited Reports Fourth Quarter and Full Year 2018 Unaudited Financial Results
iClick Interactive Asia Group Limited (“iClick”) (NASDAQ: ICLK), a leading independent online marketing and data technology platform in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31,...
Mar 25, 2019 07:00 ET
Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, today reported financial results for the fourth quarter and year ended December 31, 2018. “We made...
Mar 25, 2019 07:00 ET
Levyx Technology Selected by FX Market Leader Cobalt for Its Large-Scale Distributed Data Immutability Solution
Levyx Inc., whose high-performance, ultra-low latency data processing software simplifies Big Data infrastructure implementations, announced today the signing of a license agreement with London-based fintech, Cobalt.  As part of the agreement,...
Mar 25, 2019 07:00 ET
Market Trends Toward New Normal in Louisiana-Pacific, The Michaels Companies, VEREIT, CymaBay Therapeutics, CareDx, and Harsco — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Louisiana-Pacific Corporation (NYSE:LPX), The Michaels Companies, Inc....
Mar 25, 2019 07:00 ET
MediWound Reports Fourth Quarter and Fiscal Year 2018 Financial Results
MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced financial results for the quarter and year ended December 31,...
Mar 25, 2019 07:00 ET
Notice of Results
Summit Therapeutics plc  (‘Summit’ or the ‘Company’) Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2019 Oxford, UK, and Cambridge, MA, US, 25 March 2019 – Summit Therapeutics plc...
Mar 25, 2019 07:00 ET
Paula's Choice Achieves 40% Lift in Revenue with Progressive Web App from Mobify
An A/B test of beauty innovator Paula’s Choice Skincare’s Progressive Web App (PWA) from Mobify has yielded a 40% increase in revenue and a 46% rise in conversion rate. Retailers and brands driving digital transformation rely on Mobify as the...
Mar 25, 2019 07:00 ET
Publication Identifies Cyclin E as Key Resistance Pathway to Breast Cancer Treated by CDK4/6 Inhibitors and Thereby Amenable to Treatment by CYC065 CDK2/9 Inhibitor
Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing innovative medicines based on cancer cell biology, highlighted a paper from independent investigators titled Cyclin E1...
Mar 25, 2019 07:00 ET
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care settings, today announced the appointment of Arnaud Ajdler to the Company’s Board of Directors. Mr....
Mar 25, 2019 07:00 ET
RioCan Real Estate Investment Trust Announces Agreement of Edward Sonshine, O.Ont., Q.C. to Remain as Chief Executive Officer Until at Least March 31, 2021; Jonathan Gitlin Appointed President and Chi
RioCan Real Estate Investment Trust (“RioCan” or the “Trust”) (TSX:REI.UN) is pleased to announce that Edward Sonshine, O.Ont., Q.C., RioCan’s Chief Executive Officer, has agreed to remain Chief Executive Officer of the Trust until his retirement...